Patents by Inventor Wilfried Renner

Wilfried Renner has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR THE DIAGNOSIS AND TREATMENT OF CARDIOVASCULAR DISEASES
    Publication number: 20120065078
    Abstract: The present invention refers to a method for the in vitro or in vivo diagnosis of cardiovascular diseases, in particular high blood pressure, stenosis, vessel occlusion and/or other thrombotic events, wherein the nucleotide at position 950 of a nucleic acid coding for the human ARK2 protein or the amino acid at position 298 of the human ARK2 protein of a sample of a person is determined as well as to the use of ARK2 for the development and/or production of a medicament for treating a cardiovascular disease.
    Type: Application
    Filed: November 17, 2011
    Publication date: March 15, 2012
    Applicant: SANOFI
    Inventors: Detlef KOZIAN, Matthias HERRMANN, Thomas LEEUW, Wilfried RENNER, Winfried MAERZ
  • Method for the diagnosis and treatment of cardiovascular diseases
    Patent number: 8071297
    Abstract: The present invention refers to a method for the in vitro or in vivo diagnosis of cardiovascular diseases, in particular high blood pressure, stenosis, vessel occlusion and/or other thrombotic events, wherein the nucleotide at position 950 of a nucleic acid coding for the human ARK2 protein or the amino acid at position 298 of the human ARK2 protein of a sample of a person is determined as well as to the use of ARK2 for the development and/or production of a medicament for treating a cardiovascular disease.
    Type: Grant
    Filed: November 23, 2006
    Date of Patent: December 6, 2011
    Assignee: Sanofi-Aventis
    Inventors: Detlef Kozian, Matthias Herrmann, Thomas Leeuw, Wilfried Renner, Winfried Maerz
  • METHOD FOR THE DIAGNOSIS AND TREATMENT OF CARDIOVASCULAR DISEASES
    Publication number: 20090239218
    Abstract: The present invention refers to a method for the in vitro or in vivo diagnosis of cardiovascular diseases, in particular high blood pressure, stenosis, vessel occlusion and/or other thrombotic events, wherein the nucleotide at position 950 of a nucleic acid coding for the human ARK2 protein or the amino acid at position 298 of the human ARK2 protein of a sample of a person is determined as well as to the use of ARK2 for the development and/or production of a medicament for treating a cardiovascular disease.
    Type: Application
    Filed: November 23, 2006
    Publication date: September 24, 2009
    Applicant: SANOFI-AVENTIS
    Inventors: Detlef Kozian, Matthias Herrmann, Thomas Leeuw, Wilfried Renner, Winfried Maerz